Sarepta Therapeutics
Price & Volume
Stats
See more52W Range | $102.15-$173.25 |
Market Cap | $11.1B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $1.6B |
Revenue Growth (YoY) | 40.8% |
Gross Profit (12 Mos) | $609.2M |
Diluted EPS | $1.55 |
News
See moreYahoo Finance • 4 months ago
Exploring TeraWulf And Two Other High Growth Tech Stocks
Yahoo Finance • 5 months ago
Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Yahoo Finance • 6 months ago
This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes
Yahoo Finance • 8 months ago
Is Sarepta Therapeutics, Inc. (NASDAQ:SRPT) A Good Fast Growth Stock To Buy?
About
CEO | Mr. Douglas S. Ingram Esq. |
CFO | Mr. Ian Michael Estepan |
Address | 215 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,314 |
